Schedule 13G ownership disclosure

Prometheus Biosciences, Inc.

Security class unavailable

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-22-001019
Form type
SC 13G
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Jun 07, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub